A little off-topic, but part of the problem with personalized medicine I think is that the target market for any drug developed for a particular personalization is necessarily small. In other words, right now it is a bad business decision. Perhaps it can be used as a delta- to a mass-market drug in the future, like seasonings to a basic recipe, but that's a bit off.